Butterfly Network (BFLY) Stock News

Butterfly Network and Edward via College of Osteopathic Medicine announced a long-term alliance to build a new model for ultrasound education. The partnership focuses on integrating handheld ultrasound into medical training.

Canaccord Genuity started Butterfly Network (BFLY) coverage at Buy with a $10 price target. The call implies upside from current trading levels and reflects the analyst’s constructive view on the portable ultrasound maker's market position and growth prospects.

Canaccord Genuity initiated coverage of Butterfly Network with a Buy rating. No price target was disclosed.

Bridge Neurotech emerged from stealth and will license Butterfly Network's Ultrasound-on-Chip technology to develop a non-surgical brain-computer interface. The multi-year agreement includes milestone payments and hardware commitments. Bridge also opened enrollment for its first human research study.

Needham initiated coverage of Butterfly Network (BFLY) with a Buy rating and a $10 price target. The analyst sees potential for the company's chip-based ultrasound technology to expand into broader medical-device markets beyond handheld ultrasound, and expects multiple near-term growth catalysts for its core platform.